MAY 06, 2019 7:17 AM PDT

New insights on childhood cancer

Malignant rhabdoid tumor (MRT) is one of the worst cancer diagnoses a child can receive. While it is uncommon (or perhaps because it is), there are no standard effective treatments for MRT and most children will survive under a year.

MRT is so aggressive because it involves the loss of an anti-cancer protein called SNF5. The inactivation of SNF5 means that tumors are not suppressed; at the same time, the lost SNF5 also enables a pro-cancer protein called MYC to accelerate cancerous growth. Understanding this relationship has guided new research from Vanderbilt University, as scientists believe that targeting MYC in MRT patients might provide an effective treatment option.

"One of the difficulties in treating a cancer like MRT is that it's driven by the loss of a particular protein from the tumor cell," said William Tansey, PhD, Ingram Professor of Cancer Research and Professor of Cell and Developmental Biology. "Showing that MYC is activated by SNF5 loss identifies a target you can conceivably go after in these cancers," he said.

MRT cancer is one of the most aggressive pediatric cancers. Photo: Pixabay

MYC refers to a group of three related proteins that work as transcriptional regulators, meaning they control the expression of many genes linked to cell growth, proliferation, metabolism and genomic instability. In people with cancer, these proteins are expressed too much, which result in malignant tumors and cancerous growth. MYC overexpression leads to 100,000 cancer deaths annually in the United States.

Tansey and his colleagues are hoping that this new understanding of the connection between SNF5 and MYC proteins will promote future research in the field. As reported by Science Daily, the team of researchers utilized biochemical and genomic approaches to show that “SNF5 selectively inhibited binding of MYC to DNA, something that is required for its tumorigenic function. Accordingly, the reintroduction of SNF5 into MRT cells also displaced MYC from chromatin (the complex of DNA, RNA and protein that form chromosomes), inhibiting pro-cancerous gene expression programs.”

The research was published recently in the journal Nature Communications.

Sources: Nature Communications, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 26, 2021
Genetics & Genomics
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
JUL 26, 2021
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
Many types of cells have to be replenished continuously throughout our lives, and the genome in the nucleus of those cel ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 18, 2021
Technology
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
AUG 18, 2021
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment ...
OCT 24, 2021
Microbiology
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
OCT 24, 2021
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
Bacteria can be found almost everywhere, and they can serve many beneficial purposes. Scientists are now using bacterial ...
NOV 09, 2021
Immunology
Wikipedia, but Make It Immune Cells
NOV 09, 2021
Wikipedia, but Make It Immune Cells
Scientists have established the first searchable database of complex immune data, providing the foundations for a new er ...
NOV 29, 2021
Microbiology
How the Hepatitis B Virus Promotes Liver Cancer Development
NOV 29, 2021
How the Hepatitis B Virus Promotes Liver Cancer Development
It's estimated that about 240 million people worldwide have an HBV infection. Hepatitis B infections are linked to t ...
Loading Comments...